1,000 Strong: Rare Disease Advocates Pitch for Billions in Research from California Stem Cell Agency

Keep hope on the horizon, say the advocates

Jun 26, 2024

∙ Paid

This is from a presentation scheduled for Thursday’s CIRM board meeting. It reflects the latest staff thinking on the revision of CIRM’s priorities on award spending.

In an impassioned plea by 1,005 persons, California’s stem cell and gene therapy agency is being urged to spend billions of dollars on clinical research for rare diseases as the agency is i…

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.